Medicare Advantage patients find themselves in regulatory limbo

By Fred Schulte

States lack oversight but feds are struggling to keep with fast-growing health plans.

Feds seek new authority to recoup Medicare Advantage overcharges

By Fred Schulte

Impact: Feds act to recoup overcharges following Center investigation.

Medicare Advantage lobbying machine steamrolls Congress

By Fred Schulte

Under pressure, Medicare Advantage critics morph into defenders.

Excerpts from this story referencing "Center for Responsive Politics":

"… s industry over the past three election cycles, according to data from the Center for Responsive Politics. Franken alone has received at least $90,000 from the health services indu …"

Methodology for 'Medicare Advantage Money Grab'

By David Donald and Erin Durkin

A behind-the-scenes look at the data analysis for the 'Medicare Advantage Money Grab' investigation.

Medicare Advantage made simple: a glossary

By Fred Schulte

Definitions for lesser-known terms relating to Medicare.

OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Excerpts from this story referencing "pharmaceutical industry":

"… s.  Before the Medicare Part D drug program was created in 2006, the pharmaceutical industry paid rebates to the government to help pay for those folks’ medications. …"

"… s to help save a program that they benefit from:  “R&D (in the pharmaceutical industry) is critical to the country’s long term economic growth and to important …"

OPINION: Big Pharma's stranglehold on Washington

By Wendell Potter

Pharmaceutical firms are getting their money's worth on Capitol Hill.

Excerpts from this story referencing "pharmaceutical industry":

"… regulations.   In both cases, you’d be wrong. It’s actually the pharmaceutical industry that spends the most each year to influence our lawmakers, forking over a …"

"… d news for Medicare beneficiaries, of course, but even better news for the pharmaceutical industry. That’s because the industry’s friends in Congress (and the White Hous …"

"… the many problematic issues that Congress’ hands-off attitude toward the pharmaceutical industry has on the American health care consumer — both on pricing and on drug m …"

Medicare: An entitlement out of control

By David Nather

If Congress had known in 1965 how expensive Medicare would become, it might not have approved the program in the first place. So Lyndon John

Medicare patients received expired, terminated drugs

By Joe Eaton

Medicare patients in 2006-07 likely received more than $112 million worth of expired prescription drugs or drugs that have been pulled from

GAO says Medicare regulator followed the rules in Humana smackdown

By Joe Eaton

The Government Accountability Office is siding with Medicare administrators in a dispute with Humana Inc.— the nation’s largest private heal

Drug makers' dime funds Congressional travel

By Robert Brodsky

Pharmaceutical companies, affiliated trade groups spent more than $600,000 on trips

Excerpts from this story referencing "Pharmaceutical Research and Manufacturers of America":

"… of travel.The drug industry's largest and most influential lobbying group, Pharmaceutical Research and Manufacturers of America (PhRMA), paid for 45 trips worth at least a combined $92,000. Nearly half …"

Drug industry influence timeline

What the pharmaceutical industry has gotten on its political investment

Excerpts from this story referencing "Medicare Part D":

"… addition to the cost of the vaccine itself) is included in the coverage of Medicare Part D drugs.In June, House Democrats announce plans to introduce legislation pre …"